Agilon Health (NYSE:AGL) Shares Down 6.1% – Should You Sell?

Shares of Agilon Health, Inc. (NYSE:AGL) fell 6.1% during mid-day trading on Wednesday . The stock traded as low as $107.75 and last traded at $106.3050. 18,677 shares were traded during trading, a decline of 95% from the average session volume of 350,562 shares. The stock had previously closed at $113.27.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on AGL. Robert W. Baird lifted their price target on Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Benchmark reiterated a “buy” rating and set a $95.00 price target (up from $13.00) on shares of Agilon Health in a research report on Thursday, May 21st. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $33.00 to $49.00 in a research report on Thursday, May 7th. Finally, JPMorgan Chase & Co. lowered Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price objective for the company. in a research note on Monday, May 4th. Five analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $58.73.

Agilon Health Trading Down 1.5%

The stock has a market cap of $1.86 billion, a price-to-earnings ratio of -5.17 and a beta of 3.02. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08. The business has a 50-day moving average of $61.29 and a 200-day moving average of $32.15.

Agilon Health (NYSE:AGL) last released its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.04 by $0.76. The firm had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. As a group, research analysts forecast that Agilon Health, Inc. will post -3.5 earnings per share for the current year.

Hedge Funds Weigh In On Agilon Health

Several institutional investors have recently bought and sold shares of AGL. Wealthcare Advisory Partners LLC bought a new position in Agilon Health during the third quarter valued at about $26,000. LPL Financial LLC raised its holdings in Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after buying an additional 30,000 shares in the last quarter. Krilogy Financial LLC bought a new position in Agilon Health during the fourth quarter valued at about $34,000. CIBC Bancorp USA Inc. bought a new position in Agilon Health during the third quarter valued at about $34,000. Finally, Merit Financial Group LLC bought a new position in Agilon Health during the fourth quarter valued at about $35,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.